Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function-Reference-Cited by-同舟云学术

Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function

Published:2019-09-26 Issue:4 Volume:35 Page:521-530
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Nagano Nobutaka,Yano Toshiyuki^ORCID,Fujita Yugo,Kouzu Hidemichi,Koyama Masayuki,Ikeda Hiroshi,Yasui Kenji,Muranaka Atsuko,Nishikawa Ryo,Takahashi Ryo,Kishiue Naohiro,Yuda Satoshi,Miura Tetsuji

Funder

the Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-019-01513-y.pdf

Reference34 articles.

1. Merlini G, Dispenzieri A, Sanchorawala V, Schönland SO, Palladini G, Hawkins PN, Gertz MA (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4:38

2. Kastritis E, Dimopoulos MA (2016) Recent advances in the management of AL amyloidosis. Br J Haematol 172:170–186

3. Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, Laumann K, Zeldenrust SR, Leung N, Dingli D, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Gertz MA (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 30:989–995